- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 487/10
Total number of patents in this class: 1892
10-year publication summary
|
89
|
113
|
133
|
174
|
137
|
149
|
192
|
208
|
196
|
119
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
49 |
| Hoffmann-La Roche Inc. | 3418 |
48 |
| Boehringer Ingelheim International GmbH | 4650 |
47 |
| F. Hoffmann-La Roche AG | 7925 |
46 |
| Enanta Pharmaceuticals, Inc. | 428 |
31 |
| Novartis AG | 10849 |
30 |
| Tenacia Biotechnology (Hong Kong) Co., Limited | 36 |
30 |
| The Regents of the University of Michigan | 4698 |
28 |
| Takeda Pharmaceutical Company Limited | 2713 |
27 |
| Janssen Pharmaceutica N.V. | 3392 |
26 |
| Merck Patent GmbH | 5831 |
26 |
| Merck Sharp & Dohme LLC | 3748 |
26 |
| Amgen Inc. | 4074 |
25 |
| The Regents of the University of California | 19918 |
22 |
| AstraZeneca AB | 2909 |
21 |
| Daiichi Sankyo Company, Limited | 1869 |
21 |
| Gilead Sciences, Inc. | 2036 |
21 |
| Araxes Pharma LLC | 91 |
20 |
| Pfizer Inc. | 3387 |
18 |
| Arvinas Operations, Inc. | 229 |
17 |
| Other owners | 1313 |